Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells

Journal of Virology

Volumn 70, Issue 6, 1996, Pages 3561-3570

  Schlager, Sabine ^a,b   Speck, Samuel H ^c   Woisetschlger, Maximilian ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b UNIVERSITY OF GRAZ   (Austria)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; VIRUS NUCLEOPROTEIN;

ARTICLE; B LYMPHOCYTE ACTIVATION; CELL IMMORTALIZATION; GENE SWITCHING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION; VIRUS CHARACTERIZATION; VIRUS EXPRESSION; VIRUS INDUCTION; VIRUS INFECTION; VIRUS LATENCY; VIRUS TRANSCRIPTION;

EID: 0030014165     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.6.3561-3570.1996     Document Type: Article

References (44)

1. Aman, P., J. Gordon, N. Lewin, M. Nordstrom, B. Ehlin-Henriksson, G. Klein, and A. Carstensson. 1985. Surface marker characterization of EBV target cells in normal blood and tonsil B lymphocyte populations. J. Immunol. 135:2362-2367.
2. 1a.Auffray, C., and F. Rougeon. 1980. Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur. J. Biochem. 107:303-314.
3. Banchereau, J., P. dePaoli, A. Valle, E. Garcia, and F. Rousset. 1991. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 251:70-72.
4. Brandsma, J., and G. Miller. 1980. Nucleic acid spot hybridization: rapid quantitative screening of lymphoid cell lines for Epstein-Barr viral DNA. Proc. Natl. Acad. Sci. USA 77:6851-6855.
5. Calender, A., M. Billaud, J. P. Aubry, J. Banchereau, M. Vuillaume, and G. M. Lenoir, 1987. Epstein-Barr virus (EBV) induces expression of B cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. Proc. Natl. Acad. Sci. USA 84:8060-8064.
6. Chujor, C. S. N. B. Kuhn, B. Schwerer, H. Bernheimer, W. R. Levis, and D. Bevec. 1992. Specific inhibition of mRNA accumulation for lymphokines in human T cell line Jurkat by mycobacterial lipoarabinomannan antigen. Clin. Exp. Immunol. 87:398-403.
7. Farrell, P. J. 1989. Epstein-Barr virus genome, p. 103-132. In G. Klein (ed.), Advances in viral oncology, vol. 8. Raven Press, New York.
8. Gahn, T. A., and B. Sugden. 1995. An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene. J. Virol. 69:2633-2636.
9. Gordon, J., L. Walker, G. Guy, G. Brown, M. Rowe, and A. Rickinson. 1986. Control of human B-lymphocyte replication. II. Transforming Epstein-Barr virus exploits three distinct viral signals to undermine three separate control points in B cell growth. Immunology 58:591-595.
10. Hsieh, J. J.-D., and S. D. Hayward. 1995. Masking of the CBF1/RBPJk transcriptional repression domain by Epstein-Barr virus EBNA2. Science 268:560-563.
11. Kempkes, B., D. Spitkovsky, P. Jansen-Duerr, J. W. Ellwart, E. Kremmer, H. J. Delecluse, C. Rottenberger, G. W. Bornkamm, and W. Hammer-Schmidt. 1995. BB cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2. EMBO J. 14:88-96.
12. Kieff, E., and D. Liebowitz. 1990. Epstein-Barr virus and its replication, p. 1889-1920. In B. N. Fields and D. M. Knipe (ed.), Virology, 2nd ed. Raven Press, New York.
13. Lear, A. L., M. Rowe, M. G. Kurilla, S. Lee, S. Henderson, E. Kieff, and A. B. Rickinson. 1992. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle. J. Virol. 66:7461-7468.
14. Ling, P. D., J. J.-D. Hsieh, I. K. Ruf, D. R. Rawlins, and S. D. Hayward. 1994. EBNA 2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1. J. Virol. 68:5375-5383.
15. Miller, G., and M. Lipman. 1973. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc. Natl. Acad. Sci. USA 70:190-194.
16. 14a.Puglielli, M. T., and S. H. Speck. Unpublished observation.
17. 14b.Puglielli, M. T., M. Woisetschläger, and S. H. Speck. Unpublished data.
18. Rabson, M., L, Gradoville, L. Heston, and G. Miller. 1982. Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye. J. Virol. 44:834-844.
19. Rawlins, D. R., G. Milman, S. D. Hayward, and G. S. Hayward. 1985. Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region. Cell 42:859-868.
20. Reisman, D., and B. Sugden. 1986. trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. Mol. Cell. Biol. 6:3838-3846.
21. Rogers, R. P., M. Woisetschlaeger, and S. H. Speck. 1990. Alternative splicing dictates translational start in Epstein-Barr virus transcripts. EMBO J. 9:2273-2277.
22. Rooney, C., J. G. Howe, S. H. Speck, and G. Miller. 1989. Influences of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus. J. Virol. 63:1531-1539.
23. Rowe, M., and C. Gregory. 1989. Epstein-Barr virus and Burkitt's lymphoma, p. 237-259. In G. Klein (ed.), Advances in viral oncology, vol. 8. Raven Press, New York.
24. 20a.Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
25. Sample, J., L. Brooks, C. Sample, L. Young, M. Rowe, C. Gregory, A. Rickinson, and E. Kieff. 1991. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Proc. Natl. Acad. Sci. USA 88:6343-6347.
26. Sample, J., E. B. D. Henson, and C. Sample. 1992. The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated. J. Virol. 66:4654-4661.
27. Schaefer, B. C., J. L. Strominger, and S. H. Speck. 1995. The Epstein-Barr virus BamHI F promoter is an early lytic promoter: lack of correlation with EBNA 1 gene transcription in group 1 Burkitt's lymphoma cell lines. J. Virol. 69:5039-5047.
28. Schaefer, B. C., J. L. Strominger, and S. H. Speck. 1995. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Proc. Natl. Acad. Sci. USA 92:10565-10569.
29. Schaefer, B. C., M. Woisetschlaeger, J. L. Strominger, and S. H. Speck. 1991. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes. Proc. Natl. Acad. Sci. USA 88:6550-6554.
30. Sinclair, A. J., I. Palmero, G. Peters, and P. J. Farrell. 1994. EBNA 2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO J. 13:3321-3328.
31. Speck, S. H., and J. L. Strominger. 1989. Transcription of Epstein-Barr virus in latently infected, growth-transformed lymphocytes, p. 133-150. In G. Klein (ed.), Advances in viral oncology, vol. 8. Raven Press, New York.
32. Sugden, B., and N. Warren. 1989. A promoter of Epstein-Barr virus that can function during latent infection can he transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection. J. Virol. 63:2644-2649.
33. Sung, N. S., S. Kenney, D. Gutsch, and J. S. Pagano. 1991. EBNA-2 trans-activates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus. J. Virol. 65:2164-2159.
34. Swaminathan, S., R. Hesselton, J, Sullivan, and E. Kieff. 1993. Epstein-Barr virus recombinants with specifically mutated BCFR1 genes. J. Virol. 67:7406-7413.
35. Takada, K., and Y. Ono. 1989. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J. Virol. 63:445-449.
36. 31a.Thorley-Lawson, D., and K. Mann. 1985. Early events in Epstein-Barr virus infection provide a model for B cell activation. J. Exp. Med. 162:45-59.
37. Waltzer, L., F. Logeat, C. Brou, A. Israel, A. Sergeant, and E. Manet. 1994. The human JK recombination signal sequence binding protein (RBP-JK) targets the Epstein-Barr virus EBNA 2 protein to its DNA responsive elements. EMBO J. 13:5633-5638.
38. Wang, F., C. Gregory, C. Sample, M. Rowe, D. Liebowitz, R. Murray, A. Rickinson, and E. Kieff. 1990. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA 2 and LMP1 cooperatively induce CD23. J. Virol. 64:2309-2318.
39. Woisetschlaeger, M., X. W. Jin, C. N. Yandava, L. A. Furmanski, J. L. Strominger, and S. H. Speck. 1991. Role of the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection. Proc. Natl. Acad. Sci. USA 88:3942-3946.
40. Woisetschlaeger, M., J. L. Strominger, and S. H. Speck. 1989. Mutually exclusive use of viral promoters in Epstein-Barr virus latently infected lymphocytes. Proc. Natl. Acad. Sci. USA 86:6498-6502.
41. Woisetschlaeger, M., C. N. Yandava, L. A. Furmanski, J. L. Strominger, and S. H. Speck. 1990. Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes. Proc. Natl. Acad. Sci. USA 87:1725-1729.
42. Yates, J., N. Warren, D. Reisman, and B. Sugden. 1984. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc. Natl. Acad. Sci. USA 81:3806-3810.
43. Yssel, H., J. E. DeVries, M. Koken, W. VanBlitterswijk, and H. Spits. 1984. Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones. J. Immunol. Methods 72:219-227.
44. Zimber-Strobl, U., L. J. Strobl, C. Meitinger, R. Hinrichs, T. Sakai, T. Furukawa, T. Honjo, and G. W. Bornkamra. 1994. Epstein-Barr virus nuclear antigen 2 exerts its rraruactivating function through interaction with recombination signal binding protein RBP-Jn, the homologue of Drosophila suppressor of hairless. EMBO J. 13:4973-1982.